Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cybulska

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|March 1, 1973
Studies on the intravenous fat tolerance test in patients with compensated liver cirrhosis and chronic aggressive hepatitisB Milewski, W B Szostak, W Medrzejewski, et al.
Biochimica Et Biophysica Acta|August 22, 2001
MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cellsJ Szlinder-Richert, J Mazerski, B Cybulska, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 17, 2001
[Micronized fenofibrate, decreased triglyceride levels, total cholesterol and LDL fractions in serum]B Zaborska, J Kłoś, M Sikora-Frac, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1980
The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IVB Cybulska, M Naruszewicz, L Kłosiewicz-Latoszek, et al.
Acta Biochimica Polonica|August 29, 2000
N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicityB Cybulska, I Gadomska, J Mazerski, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1979
Very low density lipoprotein (VLDL) pattern in primary hyperlipoproteinaemia type IIb and type IVL Kłosiewicz-Latoszek, M Naruszewicz, B Cybulska, et al.
Biochemical Pharmacology|March 1, 1988
Quantitative structure-activity relationships in amphotericin B derivativesM Chéron, B Cybulska, J Mazerski, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1978
An evaluation of the results of dietary treatment in obesity on outpatientsM Białkowska, W B Szostak, A Nekanda-Trepka, et al.
Acta Physiologica Polonica|January 1, 1982
Lipoprotein fractions in idiopathic hyperlipoproteinaemiaL Kłosiewicz-Latoszek, M Naruszewicz, B Cybulska, et al.
AIDS (London, England)|July 9, 1999
Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapyP S Rice, B Cybulska, J V Parry, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Polskie Archiwum Medycyny Wewnetrznej|March 1, 1973
Studies on the intravenous fat tolerance test in patients with compensated liver cirrhosis and chronic aggressive hepatitisB Milewski, W B Szostak, W Medrzejewski, et al.
Biochimica Et Biophysica Acta|August 22, 2001
MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cellsJ Szlinder-Richert, J Mazerski, B Cybulska, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 17, 2001
[Micronized fenofibrate, decreased triglyceride levels, total cholesterol and LDL fractions in serum]B Zaborska, J Kłoś, M Sikora-Frac, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1980
The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IVB Cybulska, M Naruszewicz, L Kłosiewicz-Latoszek, et al.
Acta Biochimica Polonica|August 29, 2000
N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicityB Cybulska, I Gadomska, J Mazerski, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1979
Very low density lipoprotein (VLDL) pattern in primary hyperlipoproteinaemia type IIb and type IVL Kłosiewicz-Latoszek, M Naruszewicz, B Cybulska, et al.
Biochemical Pharmacology|March 1, 1988
Quantitative structure-activity relationships in amphotericin B derivativesM Chéron, B Cybulska, J Mazerski, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1978
An evaluation of the results of dietary treatment in obesity on outpatientsM Białkowska, W B Szostak, A Nekanda-Trepka, et al.
Acta Physiologica Polonica|January 1, 1982
Lipoprotein fractions in idiopathic hyperlipoproteinaemiaL Kłosiewicz-Latoszek, M Naruszewicz, B Cybulska, et al.
AIDS (London, England)|July 9, 1999
Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapyP S Rice, B Cybulska, J V Parry, et al.
Pageof 8